Effects of reducing sedentary behaviour on back pain, paraspinal muscle insulin sensitivity and muscle fat fraction and their associations: a secondary analysis of a 6-month randomised controlled trial.

Virva Saunavaara, Kari Kalliokoski, Harri Sievänen, Tommi Vasankari, Henri Vähä-Ypyä, Tanja Sjöros, Saara Laine, Jooa Norha, Taru Garthwaite, Eliisa Löyttyniemi, Jussi Hirvonen, Kirsi Laitinen, Noora Houttu, Ilkka Heinonen, Tiina Verho

Journal: BMJ open 2024;14(9):e084305

PMID: 39343453

Abstract

OBJECTIVES

Sedentary behaviour (SB) is a plausible intervention target for back pain mitigation. Therefore, this study aimed to investigate the effects of a 6-month SB reduction intervention on back pain and related disability outcomes, and paraspinal muscle (ie, erector spinae and transversospinales separately) insulin sensitivity (glucose uptake, GU) and muscle fat fraction (FF).

METHODS

Sixty-four adults with overweight or obesity and metabolic syndrome were randomised into intervention (n=33) and control (n=31) groups. The intervention group aimed to reduce SB by 1 hour/day (measured with accelerometers) and the control group continued as usual. Back pain intensity and pain-related disability were assessed using 10 cm Visual Analogue Scales and the Oswestry Disability Index (ODI) questionnaire. Paraspinal muscle GU was measured using 18-fluorodeoxyglucose positron emission tomography during hyperinsulinaemic-euglycaemic clamp. FF was measured using MRI.

RESULTS

Pain-related disability increased during the intervention in both groups. Back pain intensity increased significantly more in the control group than in the intervention group in which back pain intensity remained unchanged (group×time p=0.030). No statistically significant between-group changes in pain-related disability, ODI or paraspinal GU and FF were observed. In the whole study group, the change in daily steps was associated positively with the change in paraspinal muscle GU.

CONCLUSION

An intervention focusing on SB reduction may be feasible for preventing back pain worsening regardless of paraspinal muscle GU or FF.

TRIAL REGISTRATION NUMBER

NCT03101228.

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Address: Turku University Hospital, Turku, Finland [email protected].; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.; Turku University Hospital, Turku, Finland.; Department of Medical Physics, Turku University Hospital, Turku, Finland.; Institute of Biomedicine & Functional Foods Forum, University of Turku, Turku, Finland.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland.; UKK-Institute, Tampere, Finland.; Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; UKK-Institute, Tampere, Finland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.